223 related articles for article (PubMed ID: 25157856)
1. Tumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.
Magnussen S; Hadler-Olsen E; Latysheva N; Pirila E; Steigen SE; Hanes R; Salo T; Winberg JO; Uhlin-Hansen L; Svineng G
PLoS One; 2014; 9(8):e105929. PubMed ID: 25157856
[TBL] [Abstract][Full Text] [Related]
2. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
[TBL] [Abstract][Full Text] [Related]
3. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
4. Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.
Ghosh S; Koblinski J; Johnson J; Liu Y; Ericsson A; Davis JW; Shi Z; Ravosa MJ; Crawford S; Frazier S; Stack MS
Mol Cancer Res; 2010 Feb; 8(2):145-58. PubMed ID: 20145038
[TBL] [Abstract][Full Text] [Related]
5. Organ specific regulation of tumour invasiveness and gelatinolytic activity at the invasive front.
Hadler-Olsen E; Wetting HL; Ravuri C; Omair A; Rikardsen O; Svineng G; Kanapathippillai P; Winberg JO; Uhlin-Hansen L
Eur J Cancer; 2011 Jan; 47(2):305-15. PubMed ID: 20932741
[TBL] [Abstract][Full Text] [Related]
6. [Expressions and clinical significance of urokinase-type plasminogen activator (uPA) and uPA receptor (uPAR) in tongue squamous cell carcinoma].
Wang QX; Wang TX; Sun CF; Zhang J
Shanghai Kou Qiang Yi Xue; 2006 Feb; 15(1):85-7. PubMed ID: 16525618
[TBL] [Abstract][Full Text] [Related]
7. Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas.
Shi Z; Liu Y; Johnson JJ; Stack MS
Mol Cell Biochem; 2011 Nov; 357(1-2):151-61. PubMed ID: 21630091
[TBL] [Abstract][Full Text] [Related]
8. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
[TBL] [Abstract][Full Text] [Related]
9. Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.
Zhang J; Sud S; Mizutani K; Gyetko MR; Pienta KJ
Neoplasia; 2011 Jan; 13(1):23-30. PubMed ID: 21245937
[TBL] [Abstract][Full Text] [Related]
10. Heat shock proteins HSP70 and MRJ cooperatively regulate cell adhesion and migration through urokinase receptor.
Lin Y; Peng N; Zhuang H; Zhang D; Wang Y; Hua ZC
BMC Cancer; 2014 Aug; 14():639. PubMed ID: 25175595
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study.
Bacchiocchi R; Rubini C; Pierpaoli E; Borghetti G; Procacci P; Nocini PF; Santarelli A; Rocchetti R; Ciavarella D; Lo Muzio L; Fazioli F
BMC Cancer; 2008 Aug; 8():220. PubMed ID: 18673553
[TBL] [Abstract][Full Text] [Related]
12. Macrophages of M1 phenotype have properties that influence lung cancer cell progression.
Hedbrant A; Wijkander J; Seidal T; Delbro D; Erlandsson A
Tumour Biol; 2015 Nov; 36(11):8715-25. PubMed ID: 26050228
[TBL] [Abstract][Full Text] [Related]
13. Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells.
Raghu H; Sodadasu PK; Malla RR; Gondi CS; Estes N; Rao JS
BMC Cancer; 2010 Nov; 10():647. PubMed ID: 21106094
[TBL] [Abstract][Full Text] [Related]
14. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.
Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS
J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
[TBL] [Abstract][Full Text] [Related]
15. Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.
Zhuang T; Chelluboina B; Ponnala S; Velpula KK; Rehman AA; Chetty C; Zakharian E; Rao JS; Veeravalli KK
BMC Cancer; 2013 Dec; 13():590. PubMed ID: 24325546
[TBL] [Abstract][Full Text] [Related]
16. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
[TBL] [Abstract][Full Text] [Related]
17. Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma.
Wang J; Guo F; Wei H; Dong J; Wu J
Br J Oral Maxillofac Surg; 2006 Dec; 44(6):515-9. PubMed ID: 16356605
[TBL] [Abstract][Full Text] [Related]
18. Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.
Elumalai P; Brindha Mercy A; Arunkamar R; Sharmila G; Bhat FA; Balakrishnan S; Raja Singh P; Arunakaran J
Cell Prolif; 2014 Dec; 47(6):540-52. PubMed ID: 25377085
[TBL] [Abstract][Full Text] [Related]
19. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
Christensen A; Kiss K; Lelkaitis G; Juhl K; Persson M; Charabi BW; Mortensen J; Forman JL; Sørensen AL; Jensen DH; Kjaer A; von Buchwald C
BMC Cancer; 2017 Aug; 17(1):572. PubMed ID: 28841839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
